Ongoing discussions are happening with governments around the world to continue to manage the spread of COVID-19. Today I met with Japan PM @sugawitter to discuss delivery of additional doses of the Pfizer-BioNTech #COVID19 vaccine & shared my hopes for a safe @Olympics in Tokyo.
Pfizer announced the start of a clinical study evaluating the safety of an oral #antiviral investigational drug candidate for SARS-CoV-2 infections. #COVID19 Learn more: #PFEColleague https://t.co/3BVacCIQpK
We’re ready for another 170+ years of breakthroughs, but first, a look back at where we have been. #sciencewillwin#PFEColleague https://t.co/EQtzvLyst1
NEWS: The Pfizer-@BioNTech_Group#COVID19 vaccine has not been approved or licensed by the @US_FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16 & older. See conditions of use: https://t.co/RbC0OwSEEi
NEWS: @NEJM published safety and final efficacy results from the Phase 3 trial of our #COVID19 vaccine, developed w/ @BioNTech_Group, confirming the candidate was well tolerated & demonstrated a 95% efficacy in those who participated in the trial. https://t.co/Ixg4I6qkWp
#COVID19 UPDATE: We will submit a request today to the @US_FDA for Emergency Use Authorization (EUA) of our mRNA vaccine candidate with @BioNTech_Group. #PFEColleague https://t.co/ldLEYIamIV
In a recent LinkedIn post, Pfizer’s CEO Albert Bourla outlines the economic and societal value that rapid, reliable delivery of a #COVID19 vaccine could bring: https://t.co/QDQ5O4krHe #PFEColleague https://t.co/ABmWbAYNPD
Evidence of efficacy, safety & consistent manufacturing are 3 requirements that @Pfizer must demonstrate to seek Emergency Use Authorization for its potential #COVID19 vaccine. Learn more about these key areas: #PFEColleague https://t.co/jDxq4M5yaJ
I am extremely #PfizerProud that we are one step closer to potentially delivering a #COVID19 vaccine that could help halt this pandemic. #PFEColleague https://t.co/JgkqpVWDUx
We are one step closer to potentially providing people with a much-needed breakthrough to help bring an end to this global pandemic. Hear from @Pfizer’s Chairman & CEO @AlbertBourla at the link below. #PfizerProud#PFEColleague https://t.co/gzs7YYBblT
Congratulations to all our colleagues supporting Rare Disease who made a difference through the work they did to bring this great product to market. #PfizerProud#ScienceWillWin#PFEColleague https://t.co/jSKHBOrgbV
#PfizerProud of all the innovation and effort being undertaken to manufacture and deliver our #COVID19 vaccine. Hear more from Tanya Alcorn, Vice President of Pfizer’s Biopharmaceuticals Global Supply Chain, via the Wall Street Journal. #PFEColleague https://t.co/pLTW8HradP
“Ensuring over a billion people globally have access to our potential vaccine is as critical as developing the vaccine itself.” See how Pfizer is preparing to deliver up to 100 million doses of a #COVID19 vaccine this year and another 1.3 billion in 2021. https://t.co/RWmKyIwHB9
#PfizerProud that our Angela Hwang, Group President of Pfizer Biopharmaceuticals, has been recognized at #16 on Fortune’s Most Powerful Women list in 2020! #FortuneMPW#PFEColleague https://t.co/l7Gq0oAQay
Our CEO @AlbertBourla has written an open letter to provide clarity around the development of our investigational #COVID19 vaccine. #PFEColleague https://t.co/ySZfwnM7ST
I'm #PfizerProud to stand with our Chairman and CEO @AlbertBourla as he talks about what Pfizer is doing to build a safe and effective #COVID19 vaccine candidate and the need to build trust in the science. #PFEColleague https://t.co/9B54T21w5Y